Trial Information

Summary: Pioglitazone Asthma Clinical Trial

NIH Clinical Research Center
Department of Health & Human Services (DHHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Pulmonary and Vascular Medicine Branch
Bethesda, MD 20892

Patients with asthma who are taking inhaled corticosteroids may be eligible to participate in a study at the NIH Clinical Research Center. The purpose of this study is to determine if a widely used agent for diabetes can improve asthma. Eligible patients will receive a comprehensive evaluation at the Clinical Research Center in Bethesda, Maryland. There is no cost for participating in the study.

For further information, please contact our research coordinator, toll free, at
1-877-NIH-LUNG (1-877-644-5864), extension 2
or via e-mail at LungStudy@nhlbi.nih.gov.

You may also contact the NIH Patient Recruitment and Public Liaison Office via TTY 1-866-411-1010.

For more information, please visit:

http://clinicalstudies.info.nih.gov/cgi/wais/bold032001.pl?A_08-H-0047.html@Asthma

or

http://clinicaltrials.gov/ct2/show/NCT00604578?term=asthma&rank=94

If you would like to learn more about participating in this study, please send an e-mail message using the form below.